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Bone and dentin are mineralized extracellular matrices produced by osteoblasts and odontoblasts, re-
spectively, and their major organic portion is type I collagen. Dentinogenesis Imperfecta (DGI) is one of
the most common clinically- and genetically-based disturbances of dentin formation, causing irreversible
dentin defects. Among several types of DGI, patients with DGI type II exhibit opalescent dentin with
partial or complete pulp obliteration. It has been previously reported that the non-sense mutation
(c.133C4T) in Dentin Sialophosphoprotein (DSPP) was identiﬁed in DGI type II patients at glutamine
residue 45, resulting in the premature stop codon (p.Q45X). DSPP is known to be synthesized as a single
gene product and further processed at Gly462-Asp463, resulting in the production of Dentin Sialoprotein
(DSP) and Dentin Phosphoprotein (DPP). We hypothesized that the shorter form (Q45X) of N-terminal
Dentin Sialoprotein (N-DSP) may cause over-production of type I collagen protein as obliterated pulp is
occupied by dentin. To test this hypothesis, we generated mouse recombinant Glutathione-S-Transferase
(GST)-N-DSP fusion protein, and the effect of GST-N-DSP was investigated in calvarial bone explant
culture and MC3T3-E1 osteoblastic culture systems. Here we show that a signiﬁcant increase in calvarial
bone formation is observed by GST-N-DSP. GST-N-DSP accelerates MC3T3-E1 osteoblast cell growth and
proliferation and subsequent osteoblast differentiation by inducing the expression of certain osteogenic
markers such as type I collagen, Runx2, Osterix and ATF4. Interestingly, GST-N-DSP signiﬁcantly enhances
dentinogenesis marker gene expression including Dspp and Dmp1 gene expression in non-odontogenic
MC3T3-E1 cells. To rule out any artiﬁcial effect of GST-tag, we also used the synthetic peptide of N-DSP
and conﬁrmed the results of N-DSP peptide were essentially similar to those of GST-N-DSP. Taken to-
gether, our data suggest that N-DSP promotes bone formation by accelerating osteoblast cell proliferation
and subsequent osteoblast differentiation accompanied by marked up-regulation of the dentin matrix
markers, such as Dspp and Dmp1 genes.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Dentinogenesis Imperfecta (DGI, OMIM#125490) is one of
major congenital dentin defects in humans [1]. According to the
Shields's classiﬁcation in 1973 [2], DGI is further divided into
3 types, and it is known that DGI type II is characterized by ab-
normal dentin mineralization affecting both primary and perma-
nent dentition due to mutations in Dentin SialophosphoproteinB.V. This is an open access article u(DSPP) [3–6]. The prevalence of DGI has been estimated at 1 in
6000 to 8000 children in the United States [7]. The classical clinical
presentation is described as an opalescent discoloration of the
teeth with enamel that cracks and fractures from the dentin. Ex-
posed dentin undergoes rapid attrition leading to shortening the
teeth being worn down to the gingival level. The pulp chamber is
usually completely or partially obliterated by the continued de-
position of type I collagen, the most abundant protein in dentin
[8–10].
Dental pulp is a soft connective tissue that occupies a space in
the central portion of the tooth where the pulp core is present andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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servation of completely obliterated pulp in DGI type II patients
provides an interesting question; what induces and occupies pulp
space. A non-sense mutation in the human DSPP gene was iden-
tiﬁed (glutamine at residue 45) in a large Chinese family, resulting
in premature termination of the DSP peptide (c.133C4T, p.Q45X).
Patients with this particular mutation had complete pulp chamber
obliteration [3]. As DGI type II is an autosomal dominant disorder,
the truncated protein is likely expressed, which may cause pulp
obliteration. Since obliterated pulp is likely occupied by excessive
dentin / type I collagen, in this current study, we sought to de-
termine whether the N-terminal DSP fragment (referred to N-DSP,
hereafter), the DSPP gene product with c.133C4T mutation, in-
creases type I collagen production using calvarial bone explant and
MC3T3-E1 cell culture models that are known to produce type I
collagen.
Here we show proof-of-concept that N-DSP enhances calvarial
bone formation ex vivo. Our results also demonstrate that N-DSP
accelerates MC3T3-E1 osteoblast cell proliferation and subsequent
differentiation with marked upregulation of type I collagen, Dentin
sialophosphoprotein and Dmp1 gene expression.2. Materials and methods
2.1. Molecular cloning of mouse DSP expression vectors
We used N-terminal DSP (N-DSP) constructs/protein (i.e. Q48X) in
this study, which is derived from mouse DSP and equivalent to the
human Q45X mutant form. The position of glutamine (Q) at residue
45 in human DSPP corresponds to residue 48 in mouse. Mouse DSP
expression vector constructs in the pcDNA3.1-V5/His mammalian
expression vector and the pGEX-4T-1 bacterial expression vector
were generated by PCR methods as described [11]. Brieﬂy, total RNA
was extracted from mouse molar teeth (C57BL/6, 5-week-old, male),
cDNA was then synthesized and used as PCR templates. The primers
used were as follows; (pcDNA3.1-V5/His expression vector) forward
primer: 5′-GCGAATTCATAATGAAAATGAAGATAATT-3′ and reverse
primer: 5′-GCCTCGAGTGCTGCAGTTCCTGGATGTG-3′, (pGEX-4T-1
bacterial expression vector) forward primer: 5′-GCCGGATCCATTC-
CGGTTCCCCAGTTAG-3′ and reverse primer: 5′-GCCTCGAGCTATGCTG-
CAGTTCCTGGATG-3′. The PCR products were ligated into pcDNA3.1-
V5/His and pGEX4T-1 vectors and sequenced. The plasmid harboring
N-DSP cDNA including a signal peptide without stop codon followed
by C-terminal V5/His-tag (pcDNA3.1-N-DSP-V5/His vector, thus en-
coding Met1–Ala47) was generated. The.
N-terminal Glutathione-S-Transferase (GST)-tag fused to N-DSP
cDNA lacking a signal peptide but with stop codon (pGEX-4T-1-
GST-N-DSP vector, thus encoding Ile18–Ala47 plus stop codon) was
successfully generated.
2.2. Cell culture, transfection, immunoprecipitation and Western blot
analysis
The human embryonic kidney (HEK) 293 cells were maintained
in Dulbecco's modiﬁed Eagle's medium (DMEM) containing a high
concentration of glucose (4.5 mg/ml), supplemented with 10% fetal
bovine serum (FBS, Life Technologies), 100 units/ml penicillin,
100 mg/ml streptomycin in a 5% CO2 atmosphere at 37 °C as pre-
viously described [11]. The HEK293 cells were plated onto 6 well
culture plates at a density of 3105 cells/well and transiently
transfected with pcDNA3.1-N-DSP-V5/His or pcDNA3.1-V5/His A (a
negative control) vector using X-tremeGENE 9 DNA transfection
reagent (Roche Life Science). After 24 h of transfection, cells were
washed with phosphate buffered saline (PBS) and incubated with
serum-free media for 16 h. The conditioned media and cell lysateswere collected, immunoprecipitated (IP) with anti-V5 antibody
(Life Technologies) and subjected to Western blotting (WB) ana-
lysis using anti-V5 antibody. The same membrane was stripped by
stripping buffer, and WB with anti-DSP antibody (sc-33587, Santa
Cruz Biotechnology) was performed to verify the expression of
N-DSP-V5 protein. Chemiluminescent detection of bound anti-
bodies was determined using the ECL Western blotting detection
reagents (Amersham ECL Prime, GE Healthcare Life Sciences).
2.3. Generation of recombinant GST-N-DSP fusion protein and N-DSP
peptide
The pGEX-4T-1-GST-N-DSP or pGEX-4T-1-GST vector was
transformed into the BL21-CodonPlus bacterial strain (Agilent
Technologies), cultured, and GST-N-DSP fusion protein or GST
protein alone was generated as previously reported [11]. Aliquots
of each GST protein were mixed with SDS sample buffer, applied to
4–12% SDS-PAGE, and stained with Coomassie Brilliant Blue R-250
(CBB) (Bio-Rad). Western blot analysis with anti-DSP or anti-GST
(GE Healthcare Life Sciences) antibody was also performed as
described above and the immunoreactivity of the protein was
conﬁrmed. The synthetic mouse N-DSP peptide (IPVPQLVPLERDI-
VENSVAVPLLTHPGTAA) was obtained from Peptide 2.0, Inc.
2.4. Calvarial bone ex vivo culture
The use of animals and all animal procedures in this study were
approved by the Institutional Animal Care and Use Committee
(IACUC) of Boston University Medical Campus. This study was
carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health. Calvaria were collected from C57BL/6 neo-
nates at postnatal day 7, cut into two halves along the sagittal
suture and cultured with BGJb media containing 10% FBS, 50 mg/ml
of ascorbic acid, and 100 units / ml of penicillin and 100 mg / ml of
streptomycin. We initially treated calvarial explant cultures with
various doses of GST or GST-N-DSP (with a range of 0.22–5.0 mg/
ml) to determine the optimal concentration and found that 2 mg/
ml was enough to detect the statistically signiﬁcant increase of
bone formation in the GST-N-DSP treatment group as compared to
the GST group (data not shown). Calvarial bones were treated with
2 mg/ml of GST, GST-N-DSP, N-DSP peptide, or left untreated and
ﬁve halves of calvaria for each protein were used (n¼5) and cul-
tured for up to 14 days. The media were refreshed twice a week
with addition of exogenous proteins. At day 14, the cultured cal-
varia were ﬁxed in 10% paraformaldehyde overnight at 4 °C, dec-
alciﬁed with 10% EDTA, embedded into parafﬁn, sectioned at 5 mm,
and sections were subjected to hematoxylin and eosin (H&E)
staining. Serial sections were also subjected to Masson Trichrome
staining to visualize bone matrix.
2.5. Measurement of formed bone area by histomorphometric
analysis
Sections were stained with H&E, and their images were taken
under a light microscope. The whole area of each hemi-calvarium
was imaged using Olympus DSU microscope within 4–5 image
ﬁelds per section and these images were tiled. The margin of eo-
sinophilic bone structures including frontal and parietal bones was
then outlined using the free hand selection in the Image-J pro-
gram, and the area was calculated and determined as the formed
bone area. A total of 5 hemi-calvaria samples were used per
treatment group, and 5 sections per sample were used for quan-
tiﬁcation. The values are shown as the mean (mm2)7S.D. (n¼5)
with statistical analysis.
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MC3T3-E1 cells (Subclone 4) were maintained as described
[12]. Cells were plated in triplicate onto 24-well culture plates at a
density of 6104 cells / well and on the following day, cells were
treated with 2.0 mg/ml of GST, GST-N-DSP, N-DSP peptide, or left
untreated and cultured for up to 14 days. At intervals (days 1, 3, 7,
10 and 14), the numbers of cells were counted using a hemocyt-
ometer, and cell proliferation was measured using CyQUANT Cell
Proliferation Assay Kit (Life Technologies). Three independent ex-
periments for each assay were performed. The values are shown as
the mean7S.D. (n¼3) with statistical analysis.2.7. Real time PCR analysis
MC3T3-E1 cells were plated onto 35 mm culture dishes at a
density of 2105 cells/dish, and when cells reached conﬂuence, the
media were supplemented with 50 μg/ml of ascorbic acid and
1 mM of β-glycerophosphate. Cells were treated with proteins in
the same manner as described above and further maintained for up
to 10 days. Total RNA was extracted at days 3 and 10, and cDNA was
synthesized and used as PCR templates. Real time PCR was per-
formed and the mean fold changes in the expression of each dif-
ferentiation marker relative to that of glyceraldehyde-3-phosphate
dehydrogenase (Gapdh, 4308313) were calculated using the values
obtained from a control culture with GST treatment as a calibrator
by means of 2ΔΔCT method. Markers used were the following:
Runt-related transcription factor 2 (Runx2, Mm00501578_m1); Os-
terix (Osx, Mm00504574_m1); Collagen type 1 alpha 2 chain (Col1a2,
Mm00483888_m1); Activating transcription factor 4 (Atf4, Mm00-
515324_m1); Dspp (Mm00515667_g1); Dentin matrix protein1
(Dmp1, Mm01208363_m1). Three independent experiments were
performed and the values are shown as mean7S.D. (n¼3).Fig. 1. Expression of mouse N-DSP in mammalian and bacterial expression systems. (A, B
N-DSP (containing mouse N-terminal portion of DSP; 1–47 amino acids) fused to V5/His t
the conditioned media or cell lysates were collected, immunoprecipitated (IP) with anti-
anti-DSP (B) antibody. *; IgG light chain. (C) Expression of GST-N-DSP in bacterial express
(lane 2) were separated by 4–12% SDS-PAGE and stained with CBB. The presence of a sin
also analyzed by Western blot analysis (lanes 3–6). The immunoreactivities to anti-G
munoreactivity to anti-DSP antibody was detected only in GST-N-DSP protein (lane 6), b
protein.2.8. Statistical analysis
The difference between two groups was tested by Student t-
test and a p value below 0.05 was considered as signiﬁcant. The
statistical signiﬁcance was indicated by asterisks as follows; (*) for
po0.05 and (**) for po0.001.3. Results
3.1. N-DSP is a secretory protein
We ﬁrst tested whether mouse N-DSP (i.e. Q48X) in mamma-
lian cells was secreted. The mammalian expression vector encod-
ing N-DSP (containing mouse N-terminal portion of DSP; 1–47
amino acids) fused to V5/His tag or an empty V5/His-tag vector
(EV) was transiently transfected into HEK293 cells, the condi-
tioned media or cell lysates were collected, immunoprecipitated
(IP) with anti-V5 antibody and subjected to Western blot analysis
(WB) with either anti-V5 (A) or anti-DSP (B) antibody. Our results
showed that N-DSP was identiﬁed in the conditioned media
(Fig. 1A, lane 4), but not in cell lysates (Fig. 1A, lane 2) by means of
WB analysis with anti-V5 antibody at a molecular weight of ap-
proximately 8 kDa (3 kDa of DSPþ5 kDa of V5/His tag). The
immunoreactive band to anti-V5 antibody (indicated by an ar-
rowhead as N-DSP-V5) was also positively recognized when anti-
DSP antibody was used (Fig. 1B, lane 4). Thus, our results clearly
demonstrate that N-DSP is a secretory protein.
3.2. Generation of recombinant mouse GST-N-DSP fusion protein
The position of glutamine at residue 45 in human DSPP is
equivalent to glutamine at residue 48 in mouse DSPP. The mature
portion of mouse DSP prior to the glutamine at residue 48, i.e. I18 to
A47, followed by a stop codon was subcloned into the N-terminal) Expression of N-DSP in HEK293 cells. The mammalian expression vector encoding
ag or an empty V5/His-tag vector (EV) was transiently transfected into HEK293 cells,
V5 antibody and subjected to Western blot analysis (WB) with either anti-V5 (A) or
ion system. The equal amount (500 ng each) of GST (lane 1) and GST-N-DSP proteins
gle band in each lane conﬁrms the purity of GST proteins. The same proteins were
ST antibody were clearly detected in both GST proteins (lanes 3 and 4). The im-
ut not in GST alone (lane 5), demonstrating the successful generation of GST-N-DSP
Fig. 2. Effect of N-DSP on bone formation in calvarial bone culture system. (A, C) Calvarial bones were treated with GST, GST-N-DSP, N-DSP peptide, or untreated (n¼5 in
each group) and parafﬁn-embedded sections were prepared. The representative H&E staining images of calvarial bone section incubated with GST (A-a), GST-N-DSP (A-b),
untreated control (C-a), or N-DSP peptide (C-b) were shown. Serial sections were also stained with Masson's Trichrome and the representative images were shown (A-c; GST,
A-d; GST-N-DSP, C-a; untreated control, C-b; N-DSP peptide treatment group). Greater numbers of eosinophilic layers were identiﬁed (indicated by arrowheads) when
incubated with GST-N-DSP or N-DSP peptide, but not with GST or untreated control. These layers were Trichrome-positive, indicative of collagen. Scale bar; 0.2 mm. (B, D)
The formed bone area in GST-N-DSP or N-DSP group was signiﬁcantly increased as compared to GST or untreated control group by histomorphometric analysis. The mean
value of formed bone areas was calculated, expressed as the mean7SD (mm2) and statistically analyzed (n¼5). *; po0.05.
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GST-N-DSP fusion protein was generated. Equal amounts of GST and
GST-N-DSP proteins were separated by SDS-PAGE and stained with
CBB (Fig. 1C, lanes 1 and 2). A single band of GST-N-DSP protein was
observed at the expected molecular weight size at 29 kDa,
i.e.3 kDa DSPþ26 kDa GST tag (Fig. 1C, lane 2). The same amounts
of recombinant proteins were further analyzed by Western blot
analyses using anti-GST (Fig. 1C, lanes 3 and 4) and anti-DSP (Fig. 1C,
lanes 5 and 6) antibodies. Both recombinant proteins were im-
munoreactive to anti-GST antibody while only GST-N-DSP was de-
tected by anti-DSP antibody. These results demonstrate that re-
combinant GST-N-DSP protein was successfully puriﬁed and that
anti-DSP antibody recognizes GST-N-DSP protein.
3.3. Effect of N-DSP on calvarial bone formation
Mouse calvarial bone explant cultures were incubated with
GST-N-DSP or GST for 14 days and processed for histologicalevaluation. Multiple eosinophilic layers (indicated by arrowheads)
were observed in the calvarial culture with GST-N-DSP (Fig. 2A-b)
or with N-DSP peptide (Fig. 2C-b) while there was a single eosi-
nophilic layer with GST alone (Fig. 2A-a) or untreated (Control,
Fig. 2C-a). By Masson Trichrome staining, these layers were vi-
sualized in blue (representing newly formed bone matrices) and
red (representing existing bone matrices) (Fig. 2A-c and-d, C-c
and-d), indicating that greater amount of bone matrices, likely
composed of type I collagen were accumulated in N-DSP treated
bone cultures (Fig. 2A-d and C-d) than controls (Fig. 2A-c and C-c).
To quantitatively measure the areas of formed bone, histomor-
phometric analysis was performed. The result demonstrated that
there was a signiﬁcantly greater area of bone formation in GST-N-
DSP group than in GST control, which was about 70% of the in-
crease (Fig. 2B). The increase of bone formation was also con-
ﬁrmed when the N-DSP peptide was added to the culture, and the
formed bone area in the N-DSP peptide group was about 80% more
increased as compared to the untreated control group (Fig. 2D).
Fig. 3. Effect of N-DSP on MC3T3-E1 osteoblastic cell growth and proliferation.
MC3T3-E1 cells were left untreated or treated with GST, GST-N-DSP, or N-DSP
peptide, and further cultured for up to 14 days. At Day 1, 3, 7, 10 and 14, cell
numbers were counted (A) or cell proliferation was measured by the CyQUANT Cell
Proliferation Assay (B). Data are expressed as the mean7SD (n¼3) with statistical
analysis. *; po0.05,**; po0.001.
Fig. 4. Effect of GST-N-DSP on MC3T3-E1 osteoblast differentiation. MC3T3-E1 cells
were treated with GST or GST-N-DSP, and further cultured for up to 10 days. The
expression of osteogenic/dentinogenesis markers was analyzed by real-time PCR.
The normalized values are shown as the mean7S.D. and statistically analyzed
(n¼3). *; po0.05, **; po0.001. Runx2; Runt-related transcription factor 2, Osx;
Osterix, Atf4; Activating transcription factor 4; Col1a2; Collagen type 1 alpha 2 chain,
Dspp; Dentin sialophosphoprotein, Dmp1; Dentin matrix protein 1, Gapdh; Glycer-
aldehyde-3-phosphate dehydrogenase.
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and Control groups (Fig. 2B and D), indicating the absence of any
artiﬁcial effect of GST on bone formation.
3.4. Effect of N-DSP on cell proliferation
To further gain the biological insights into how N-DSP increases
bone formation at a cellular level, we used an immortalized os-
teoblastic cell line, MC3T3-E1 cells isolated from calvaria [13]. The
effect of N-DSP on MC3T3-E1 cell growth was analyzed by cell
counting. As the DNA content is an indicator of cell numbers, we
also used the cyanine dye CyQUANT, which binds to DNA to ana-
lyze cell proliferation. The results of cell growth by cell counting
demonstrated that both GST-N-DSP and N-DSP peptide treatment
accelerated osteoblast cell growth at days 7, 10, and 14 as com-
pared to GST and untreated controls (Fig. 3A). The accelerated
proliferation of osteoblasts by GST-N-DSP and N-DSP peptide
treatment was also veriﬁed by means of CyQUANT Cell Prolifera-
tion Assay (Fig. 3B). The data showed a signiﬁcant increase by
N-DSP treatment at days 7, 10 and 14 as compared to controls,
further demonstrating the proliferative effect of N-DSP on
osteoblasts.
3.5. Effect of N-DSP on cell differentiation
We next investigated the effect of N-DSP on osteoblast differ-
entiation by measuring the levels of osteogenic and dentinogen-
esis markers (Fig. 4). The data showed that GST-N-DSP treatment
signiﬁcantly upregulated osteogenic marker expressions including
Runx2 (14.6 fold increase), Osx (30.3 fold) and Atf4 (6.6 fold)
at day 3 as compared to GST, while at day 10, the extent of up-
regulation in these transcription factor gene expression in GST-N-
DSP group was moderate (Runx2;1.8 fold increase, Osx;1.7 fold,
and Atf4;2.2 fold). The expression of Col1a2 and Dspp wassigniﬁcantly upregulated at day 3 (6.5 fold and 3.2 fold, re-
spectively) and the expression of Dmp1, another dentinogenesis
marker was moderately upregulated (1.8 fold). The level of
higher Col1a2 gene expression was sustained (6.7 fold) in GST-
N-DSP group at day 10. Intriguingly, the expression of Dspp and
Dmp1 was further increased (9.9 fold and 3.8 fold, respec-
tively) at day 10, indicating that GST-N-DSP positively regulates
the dentinogenesis marker expression in non-odontogenic cells.4. Discussion
There have been so far 40 cases of reported DGI patients
affected by DSPP mutations, which include mis-sense, non-sense,
insertion and deletion mutations [14]. It has been reported that
many inherited diseases resulting from non-sense mutations ac-
tivate nonsense-mediated mRNA decay (NMD), leading to the
degradation of such premature termination codon (PTC)-contain-
ing mRNAs [15]. In some cases such as β-thalassemia, mutations in
β-GLOBIN do not elicit NMD pathway, resulting in the presence of
truncated β-GLOBIN protein which functions as a dominant-ne-
gative form [16]. In order for aberrant mRNA to escape from NMD
activation, it is considered that the PTC has to be located less than
50–55 nucleotides upstream of a splicing from exon-exon junction
[17]. Glutamine at residue 45, where nonsense DSP-Q45X muta-
tion is located, is the last amino acid in exon 3. This points out the
potential pathological mechanism that PTC located in this position
unlikely elicits NMD pathway, resulting in the N-DSP mRNA
translation and protein synthesis, which at least in part leads to
the DGI type II pulp phenotype. It has been previously shown that
the DSP “IPV” mutant protein, where the DGI mutations occur
within the ﬁrst three amino acids of the mature DSPP portion, was
intracellularly accumulated in the secretory pathway likely at
rough endoplasmic reticulum (rER), which presented from protein
secretion [18]. In contrast to this, our results demonstrated that
N-DSP-V5/His protein was identiﬁed in the conditioned media, but
not in the cell lysates (Fig. 1), indicating that these DSP mutants
may likely have different mechanisms to lead to the DGI
phenotypes.
Odontoblasts secrete extracellular matrix proteins, including
type I collagen and non-collagenous proteins (NCPs) during den-
tinogenesis. Among several NCPs, DSPP appears to be the major
dentin speciﬁc protein despite its temporal and less abundant
expression in other tissues such as bone, cementum, and non-
skeletal tissues [19–22]. It is known that DSPP is proteolytically
processed and 3 major cleaved products are identiﬁed, namely
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[23–25]. While it is generally accepted, based on its chemical
composition, that DPP likely plays a crucial role in controlling
dentin mineralization [26] with association with type I collagen
[27,28], the roles of DSP and DGP are not fully understood. It has
been previously reported that recombinant human DSP protein
produced in bacteria (referred as rhDSP hereafter) induces growth
and differentiation on human primary [29] and immortalized
dental pulp cells [30], and rhDSP protein used in these studies
(residues from I376 to G462) encodes a C-terminal portion of DSP
(I376–S382) and full length of DGP (S383–G462), suggesting the bio-
logical effect of the rhDSP on dental pulp cells may be due to the
function of DGP. In their studies, rhDSP treatment induces type I
collagen [29] and DSPP [30] upregulation in human dental pulp
cells. More recently, it has been reported that the recombinant
mouse C-terminal DSP fragment (rC-DSP, residues from 183 to
457) produced in bacteria enhances cell proliferation in human
periodontal ligament (PDL) cells and PDL stem cells [31]. Con-
sistent with our gene expression data (Fig. 4), a few studies have
reported that overexpression of DSPP or an exogenous rC-DSP
treatment increased the expression of osteogenic markers in-
cluding Runx2 and Osx [31,32]. Thus, it is possible to suggest that
the DSP portion within DSPP protein may play a modulatory role
in cellular functions, i.e. cell proliferation and differentiation. Our
results support this potential DSP function in cell proliferation and
differentiation, although the portion of DSP in our study, e.g.
N-DSP, differs from those previous reports (rhDSP and rC-DSP). It
has been previously shown that deletion of the entire Dspp coding
exons in mice by replacing with LacZ-neo cassette leads to the
widened predentin zone, defective dentin mineralization and al-
tered levels of proteoglycans [33]. Although Dspp deﬁciency does
not change the level of type I collagen gene expression in odon-
toblasts of Dspp null mice as compared to those in wild type mice
[33], overexpression of Dsp (residues from I18–S370) in the Dspp
null background induces dentin volume, but not dentin mineral
density [34]. As the Dsp transgene includes a portion of N-DSP, it is
possible to speculate, at least in part, that DSP plays an important
role in type I collagen gene regulation in vivo. It is likely that the
molecular mechanisms by which rhDSP, rC-DSP and N-DSP affect
cell functions may differ. Our results together with previous
ﬁndings support the biological importance of DSP portion in type I
collagen synthesis possibly through enhancing cell proliferation.
There are several reasons why we took advantage of using
MC3T3-E1 cells and calvaria instead of odontogenic cell types.
(1) There is almost no information regarding which cells are re-
sponsible for making excessive amounts of dentin in DGI type II,
resulting in the pulp obliteration, i.e. pulp cells or odontoblasts.
(2) Odontoblasts usually secrete type I collagen/ECM molecules
towards their apical direction, not basal, thus it is presumed that
pulp cells are likely responsible for DGI type II pulp phenotype.
(3) Even if the cell type responsible for pulp obliteration is likely
pulp cells, they are heterozygous population in nature. So it is
difﬁcult to determine which cell sub-population is responsible for
DGI type II pulp phenotype. (4) There are almost no “best-char-
acterized” cell lines of odontoblasts or pulp cells which have been
reported to produce Dspp as a minimum requirement of dentin
marker. (5) If cells are immortalized and forced to proliferate, they
may not enter into differentiation stage of odontoblasts, as cell
differentiation is expected when cells exit the cell cycle. Instead of
dealing with such open questions/technical concerns described,
we decided to use the spontaneously immortalized MC3T3-E1
osteoblast cell line which is a very established cell line and well-
known to produce type I collagen. Although this is not an odon-
toblast-cell line, our results showed a proof-of-concept and, to the
best of our knowledge, our current study was the ﬁrst report to
show a remarkable increase of endogenous Dspp expression by anexogenous N-DSP treatment in non-odontogenic MC3T3-E1 cells, a
lineage-committed osteoblast cell line (Fig. 4). A similar ﬁnding,
but in PDL cells, has also been reported by Lee et al. [30] that DSPP
expression was modestly induced by the exogenous addition of
rhDSP determined by a conventional RT-PCR method. Although
there have been only limited numbers of studies reported, it ap-
pears that non-odontogenic cells expressing DSPP are considered
as differentiated odontoblast-like cells [32,35]. It is thus reason-
able to speculate that a high level of DSPP expression is probably
the only prerequisite to deﬁne odontoblasts, despite a lack of a
clear standard threshold. To support this notion, no other gene
mutations than DSPP are known to cause non-syndromic dentin
phenotype in humans. It is well known that mutations in other
gene markers of odontoblast (such as DMP1, type I collagen, etc.)
cause syndromic dental and bone phenotypes in humans. Further
studies are clearly warranted to investigate the usefulness of DSP-
Q45X fragment for odontoblast lineage induction as well as de
novo dentin formation, which may further address the patho-
genesis of DGI type II phenotype.
In summary, to the best of our knowledge, our study was the
ﬁrst to show that N-DSP fragment induces bone formation in
ex vivo bone culture, at least in part by stimulating osteoblast cell
growth and differentiation levels, thereby providing a mechanism
for DSP induced anabolic effects on bone.Acknowledgements
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